https://scholars.lib.ntu.edu.tw/handle/123456789/562637
標題: | Short-course chemotherapy for isoniazid-resistant pulmonary tuberculosis | 作者: | Bai K.-J. Yu M.-C. Suo J. Chiang C.-Y. Chiang I.-H. Lin T.-P. KWEN-TAY LUH |
關鍵字: | Isoniazid-resistant pulmonary tuberculosis; Mycobacterium tuberculosis; Short-course chemotherapy | 公開日期: | 1998 | 卷: | 97 | 期: | 4 | 起(迄)頁: | 278-282 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Standard short-course chemotherapy including isoniazid, rifampicin, pyrazinamide, and ethambutol has been the recommended treatment for tuberculosis in Taiwan since November 1990. The effectiveness of this treatment was evaluated retrospectively in 108 patients with isolates resistant to isoniazid alone and 115 patients with drug-susceptible pulmonary tuberculosis diagnosed and treated at the Taiwan Provincial Chronic Disease Control Bureau from November 1990 through December 1995. The success rate of treatment was 94.4% in patients with isoniazid-resistant Mycobacterium tuberculosis strains, which was not significantly different from the 97.4% rate in patients with susceptible strains. Of the patients treated successfully, no bacteriologic relapse was found in 97 patients with isoniazid-resistant strains or 103 patients with drug-susceptible strains 12 months after the end of chemotherapy. No significant advantage in treatment outcome was found in patients infected with isoniazid-resistant strains who received chemotherapy for more than 6 months (successful treatment rate, 95.0% vs 92.8%), but the failure rate was higher in patients with a previous history of antituberculosis therapy (17.6% vs 3.3%). We conclude that short- course chemotherapy is effective for isoniazid-resistant pulmonary tuberculosis and that there is no significant difference in treatment outcome between patients with or without isoniazid-resistant disease. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/562637 | ISSN: | 0929-6646 | SDG/關鍵字: | ethambutol; isoniazid; pyrazinamide; rifampicin; adult; aged; article; controlled study; drug efficacy; female; human; lung tuberculosis; major clinical study; male; mycobacterium tuberculosis; taiwan; treatment outcome; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tuberculosis, Pulmonary |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。